查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1948231

2026年全球智慧药丸市场报告

Smart Pills Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，智慧药丸市场发展迅猛，预计将从2025年的61.1亿美元成长到2026年的67.5亿美元，复合年增长率达10.5%。过去几年的成长可归因于多种因素，例如慢性病盛行率的上升、对患者依从性监测需求的增加、数位医疗计划的扩展、先进口腔感测器的广泛应用及其在临床研究中的日益普及。

预计未来几年智慧药丸市场规模将快速成长，到2030年将达到101.3亿美元，复合年增长率（CAGR）为10.7%。预测期内的成长要素包括：对个人化医疗解决方案的需求不断增长、对数位疗法的投资增加、远端患者监护的广泛应用、智慧药物输送平台的日益普及以及对连线健诊技术的监管支持力度加大。预测期内的主要趋势包括：基于感测器的药物传输系统应用日益广泛、对药物依从性解决方案的日益重视、与行动医疗平台的融合度不断提高、智慧口腔诊断技术的扩展以及小型化电子设备的快速发展。

预计未来几年，人们对无创技术的日益青睐将推动智慧药丸市场的成长。无创技术无需切口或组织切除，从而降低患者风险并缩短恢復时间。非侵入性治疗之所以备受青睐，是因为它们在提供有效诊断和治疗效果的同时，最大限度地减轻了患者的身体负担。智慧药丸透过无需手术即可进行体内成像和生理监测，从而支持非侵入性治疗，帮助临床医生透过这种简单易吞服的装置收集诊断资讯。例如，英国国家医疗服务体系（NHS）英格兰分部于2024年3月报告称，在53家医疗机构开展的结肠胶囊内视镜（PillCam）试验计画中，已有超过5,400名患者受益。因此，人们对非侵入性治疗方式日益青睐正在推动智慧药丸市场的扩张。

预计未来几年，不断增长的医疗费用支出将推动智慧药丸市场的发展。医疗费用支出是指用于医疗服务、治疗、基础设施、研究以及旨在维护和改善健康的公共卫生计画的总支出。医疗费用支出的成长需求主要源自于慢性精神疾病盛行率的上升，这些疾病需要持续的治疗、药物和长期照护支援。医疗保健支出将透过资助创新技术来推动智慧药丸的研发，这些创新技术能够改善药物输送、监测功能并提高患者依从性。例如，根据美国联邦机构医疗保险和医疗补助服务中心（CMS）的数据，预计到2023年，全国医疗保健支出（NHE）将成长7.5%，达到4.9兆美元，占国内生产总值（GDP）的17.6%（截至2024年12月）。此外，预计2023年至2032年，全国平均医疗保健支出（NHE）将以每年5.6%的速度成长，医疗保健支出占GDP的比例预计将从2022年的17.3%上升到2032年的19.7%。因此，不断增长的医疗保健支出正在推动智慧药丸市场的成长。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球智慧药丸市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 人工智慧（AI）和自主人工智慧
    • 物联网、智慧基础设施和互联生态系统
    • 数位化、云端运算、巨量资料、网路安全
    • 生物技术、基因组学和精准医学
    • 工业4.0和智慧製造
  • 主要趋势
    • 感测器辅助药物传输系统的应用日益普及
    • 人们越来越关注药物依从性解决方案
    • 加强与行动医疗平台的整合
    • 拓展智慧口腔诊断
    • 加强小型电子设备的发展

第五章 终端用户产业市场分析

  • 医院
  • 诊断中心
  • 研究所
  • 製药公司
  • 数位医疗服务提供者

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球智慧药丸市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球智慧药丸市场规模、对比及成长率分析
  • 全球智慧药丸市场表现：规模与成长，2020-2025年
  • 全球智慧药丸市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 按学科领域
  • 食道、胃、小肠、大肠
  • 按疾病指征
  • 食道疾病、大肠疾病、小肠疾病及其他疾病适应症
  • 透过使用
  • 胶囊内视镜、病患监测、药物输送
  • 最终用户
  • 医院、诊断中心和研究机构
  • 按类型细分：食道
  • 用于诊断食道疾病的胶囊，用于监测食道动力的胶囊
  • 按类型细分：胃
  • 用于监测排放的胶囊，用于诊断胃部疾病的胶囊
  • 按类型分類的亚段：小肠
  • 用于吸收测试的胶囊，用于诊断小肠疾病的胶囊
  • 按类型分類的亚段：大肠
  • 大肠镜检查替代胶囊，用于检测结肠疾病的胶囊

第十章 区域与国家分析

  • 全球智慧药丸市场：区域分析、预测与趋势（2020-2025年、2025-2030年预测、2035年预测）
  • 全球智慧药丸市场：按国家划分，实际结果和预测，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 智慧药丸市场：竞争格局及市场占有率（2024年）
  • 智慧药丸市场：公司估值矩阵
  • 智慧药丸市场：公司概况
    • Medtronic plc
    • Olympus Corporation
    • CapsoVision Inc.
    • Novartis AG
    • Proteus Digital Health Inc.

第37章：其他领先和创新企业

  • Koninklijke Philips NV, MicroCHIPS Inc., Bio-Images Drug Delivery（BDD）Ltd., Given Imaging Ltd., Vitality Inc., Boston Scientific Corporation, HQ Inc., Fujifilm Holdings Corporation, General Electric Company, Check-Cap Ltd., IntroMedic Co. Ltd., Jinshan Science & Technology Co. Ltd., PENTAX Medical, etectRx Inc., Pixie Scientific HQ Inc.

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年智慧药丸市场：提供新机会的国家
  • 2030年智慧药丸市场：蕴藏新机会的细分市场
  • 2030年智慧药丸市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME3MSPIL03_G26Q1

Smart pills are designed for the purpose of administering medication and are equipped with electronic sensors that emit signals detectable by patches or smartphones upon ingestion. These innovative pills play a crucial role in ensuring patients' adherence to their prescribed drug regimens and enable the monitoring of medication compliance.

The primary applications of smart pills encompass capsule endoscopy, patient monitoring, and drug delivery. Patient monitoring involves the repeated or continuous tracking of various patient parameters. Smart pills are used to target specific areas within the gastrointestinal tract, including the esophagus, stomach, small intestine, and large intestine, for the treatment of conditions such as esophageal diseases, colon diseases, small bowel diseases, among others. These smart pills find utility in a variety of healthcare settings, including hospitals, diagnostic centers, and research institutes.

Tariffs are influencing the smart pills market by increasing costs of imported microelectronics, sensors, transmitters, and pharmaceutical-grade materials used in ingestible devices. Healthcare providers and research institutions in North America and Europe are most affected due to reliance on imported electronic components, while Asia-Pacific faces cost pressure on device manufacturing and exports. These tariffs are raising development and production costs and slowing commercialization timelines. However, they are also encouraging localized electronics manufacturing, domestic R&D investments, and regional partnerships to advance smart pill innovation.

The smart pills market research report is one of a series of new reports from The Business Research Company that provides smart pills market statistics, including smart pills industry global market size, regional shares, competitors with a smart pills market share, detailed smart pills market segments, market trends and opportunities, and any further data you may need to thrive in the smart pills industry. This smart pills market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The smart pills market size has grown rapidly in recent years. It will grow from $6.11 billion in 2025 to $6.75 billion in 2026 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to increasing prevalence of chronic diseases, rising need for patient compliance monitoring, expansion of digital health initiatives, availability of advanced ingestible sensors, growing clinical research adoption.

The smart pills market size is expected to see rapid growth in the next few years. It will grow to $10.13 billion in 2030 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to increasing demand for personalized medicine solutions, rising investments in digital therapeutics, expansion of remote patient monitoring, growing adoption of smart drug delivery platforms, increasing regulatory support for connected health technologies. Major trends in the forecast period include increasing adoption of sensor-enabled drug delivery systems, rising focus on medication adherence solutions, growing integration with mobile health platforms, expansion of smart ingestible diagnostics, enhanced development of miniaturized electronics.

The increasing preference for non-invasive procedures is anticipated to drive the growth of the smart pills market in the coming years. Non-invasive procedures do not involve incisions or tissue removal, thereby reducing patient risk and shortening recovery time. The growing preference for non-invasive approaches is attributed to their ability to deliver effective diagnostic and therapeutic outcomes while minimizing physical burden on patients. Smart pills support non-invasive procedures by enabling internal imaging and physiological monitoring without the need for surgical entry, allowing clinicians to collect diagnostic information through a simple swallowable device. For example, in March 2024, according to NHS England, a UK-based public health service, more than 5,400 patients benefited from colon capsule endoscopy pill-cam pilot programs across 53 sites. Therefore, the rising preference for non-invasive procedures is contributing to the expansion of the smart pills market.

The increasing healthcare expenditure is anticipated to drive the growth of the smart pills market in the coming years. Healthcare expenditure refers to the overall spending on medical services, treatments, infrastructure, research, and public health programs aimed at maintaining or improving health outcomes. The rising demand for healthcare expenditure is attributed to the growing prevalence of chronic mental health conditions, which necessitate ongoing treatment, medication, and long-term care support. Healthcare expenditure facilitates the advancement of smart pills by financing innovative technologies that improve drug delivery, monitoring capabilities, and patient adherence. For example, in December 2024, according to the Centers for Medicare and Medicaid Services (CMS), a US-based federal agency, national health expenditures (NHE) increased by 7.5% to reach $4.9 trillion in 2023, representing 17.6% of gross domestic product (GDP). Furthermore, from 2023 to 2032, average national health expenditures (NHE) are expected to grow at an annual rate of 5.6%, leading to an increase in the healthcare spending share of GDP from 17.3% in 2022 to 19.7% in 2032. Thus, the rising healthcare expenditure is fueling the growth of the smart pills market.

Major companies operating in the smart pills market are concentrating on the development of smart pills with customizable programs, including ingestible multi-sensor prototypes that support tailored drug delivery and in-vivo monitoring to improve treatment adherence and therapeutic outcomes. Customizable programs refer to firmware- or software-based control of sensing functions, data collection, and triggerable actions that clinicians or trial managers can configure for individual patients. For example, in 2025, the Interuniversity Microelectronics Centre, a Belgium-based research and innovation institute, introduced a prototype ingestible sensor for gut health monitoring that integrates multiple sensing modalities chemical, mechanical, and electrical along with onboard signal processing, power management, and real-time data transmission for remote monitoring. The prototype focuses on miniaturization and full-system integration to enable configurable sensing programs for personalized clinical applications.

Major companies operating in the smart pills market are Medtronic plc, Olympus Corporation, CapsoVision Inc., Novartis AG, Proteus Digital Health Inc., Koninklijke Philips N.V., MicroCHIPS Inc., Bio-Images Drug Delivery (BDD) Ltd., Given Imaging Ltd., Vitality Inc., Boston Scientific Corporation, HQ Inc., Fujifilm Holdings Corporation, General Electric Company, Check-Cap Ltd., IntroMedic Co. Ltd., Jinshan Science & Technology Co. Ltd., PENTAX Medical, etectRx Inc., Pixie Scientific HQ Inc., ANX Robotica Corp., RF Co. Ltd., Shenzhen Jifu Medical Technology Co. Ltd., Otsuka America Pharmaceutical Inc., Medimetrics Personalized Drug Delivery B.V., Smart Pill Inc., Medisafe Inc., AdhereTech LLC, TabSafe Medical Services Inc.

North America was the largest region in the smart pills market in 2025. Western Europe was the second-largest region in the smart pills market analysis. The regions covered in the smart pills market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the smart pills market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The smart pills market consists of sales of instruments that are used in applications such as capsule endoscopy, drug delivery, and patient monitoring. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Smart Pills Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses smart pills market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for smart pills ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The smart pills market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Target Area: Esophagus; Stomach; Small Intestine; Large Intestine
  • 2) By Disease Indication: Esophageal Diseases; Colon Diseases; Small bowel Diseases; And Other Disease Indications
  • 3) By Application: Capsule Endoscopy; Patient Monitoring; Drug Delivery
  • 4) By End User: Hospital; Diagnostic Center; Research Institute
  • Subsegments:
  • 1) By Esophagus: Diagnostic Pills For Esophageal Disorders; Pills For Monitoring Esophageal Motility
  • 2) By Stomach: Gastric Emptying Monitoring Pills; Diagnostic Pills For Gastric Disorders
  • 3) By Small Intestine: Pills For Absorption Studies; Diagnostic Pills For Small Bowel Diseases
  • 4) By Large Intestine: Colonoscopy Alternative Pills; Pills For Detecting Colorectal Disorders
  • Companies Mentioned: Medtronic plc; Olympus Corporation; CapsoVision Inc.; Novartis AG; Proteus Digital Health Inc.; Koninklijke Philips N.V.; MicroCHIPS Inc.; Bio-Images Drug Delivery (BDD) Ltd.; Given Imaging Ltd.; Vitality Inc.; Boston Scientific Corporation; HQ Inc.; Fujifilm Holdings Corporation; General Electric Company; Check-Cap Ltd.; IntroMedic Co. Ltd.; Jinshan Science & Technology Co. Ltd.; PENTAX Medical; etectRx Inc.; Pixie Scientific HQ Inc.; ANX Robotica Corp.; RF Co. Ltd.; Shenzhen Jifu Medical Technology Co. Ltd.; Otsuka America Pharmaceutical Inc.; Medimetrics Personalized Drug Delivery B.V.; Smart Pill Inc.; Medisafe Inc.; AdhereTech LLC; TabSafe Medical Services Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Smart Pills Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Smart Pills Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Smart Pills Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Smart Pills Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Biotechnology, Genomics & Precision Medicine
    • 4.1.5 Industry 4.0 & Intelligent Manufacturing
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Sensor-Enabled Drug Delivery Systems
    • 4.2.2 Rising Focus On Medication Adherence Solutions
    • 4.2.3 Growing Integration With Mobile Health Platforms
    • 4.2.4 Expansion Of Smart Ingestible Diagnostics
    • 4.2.5 Enhanced Development Of Miniaturized Electronics

5. Smart Pills Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Diagnostic Centers
  • 5.3 Research Institutes
  • 5.4 Pharmaceutical Companies
  • 5.5 Digital Health Providers

6. Smart Pills Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Smart Pills Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Smart Pills PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Smart Pills Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Smart Pills Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Smart Pills Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Smart Pills Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Smart Pills Market Segmentation

  • 9.1. Global Smart Pills Market, Segmentation By Target Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Esophagus, Stomach, Small Intestine, Large Intestine
  • 9.2. Global Smart Pills Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Esophageal Diseases, Colon Diseases, Small Bowel Diseases, Other Disease Indications
  • 9.3. Global Smart Pills Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Capsule Endoscopy, Patient Monitoring, Drug Delivery
  • 9.4. Global Smart Pills Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospital, Diagnostic Center, Research Institute
  • 9.5. Global Smart Pills Market, Sub-Segmentation Of Esophagus, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Diagnostic Pills For Esophageal Disorders, Pills For Monitoring Esophageal Motility
  • 9.6. Global Smart Pills Market, Sub-Segmentation Of Stomach, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Gastric Emptying Monitoring Pills, Diagnostic Pills For Gastric Disorders
  • 9.7. Global Smart Pills Market, Sub-Segmentation Of Small Intestine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Pills For Absorption Studies, Diagnostic Pills For Small Bowel Diseases
  • 9.8. Global Smart Pills Market, Sub-Segmentation Of Large Intestine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Colonoscopy Alternative Pills, Pills For Detecting Colorectal Disorders

10. Smart Pills Market Regional And Country Analysis

  • 10.1. Global Smart Pills Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Smart Pills Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Smart Pills Market

  • 11.1. Asia-Pacific Smart Pills Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Smart Pills Market, Segmentation By Target Area, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Smart Pills Market

  • 12.1. China Smart Pills Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Smart Pills Market, Segmentation By Target Area, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Smart Pills Market

  • 13.1. India Smart Pills Market, Segmentation By Target Area, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Smart Pills Market

  • 14.1. Japan Smart Pills Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Smart Pills Market, Segmentation By Target Area, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Smart Pills Market

  • 15.1. Australia Smart Pills Market, Segmentation By Target Area, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Smart Pills Market

  • 16.1. Indonesia Smart Pills Market, Segmentation By Target Area, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Smart Pills Market

  • 17.1. South Korea Smart Pills Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Smart Pills Market, Segmentation By Target Area, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Smart Pills Market

  • 18.1. Taiwan Smart Pills Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Smart Pills Market, Segmentation By Target Area, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Smart Pills Market

  • 19.1. South East Asia Smart Pills Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Smart Pills Market, Segmentation By Target Area, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Smart Pills Market

  • 20.1. Western Europe Smart Pills Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Smart Pills Market, Segmentation By Target Area, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Smart Pills Market

  • 21.1. UK Smart Pills Market, Segmentation By Target Area, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Smart Pills Market

  • 22.1. Germany Smart Pills Market, Segmentation By Target Area, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Smart Pills Market

  • 23.1. France Smart Pills Market, Segmentation By Target Area, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Smart Pills Market

  • 24.1. Italy Smart Pills Market, Segmentation By Target Area, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Smart Pills Market

  • 25.1. Spain Smart Pills Market, Segmentation By Target Area, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Smart Pills Market

  • 26.1. Eastern Europe Smart Pills Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Smart Pills Market, Segmentation By Target Area, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Smart Pills Market

  • 27.1. Russia Smart Pills Market, Segmentation By Target Area, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Smart Pills Market

  • 28.1. North America Smart Pills Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Smart Pills Market, Segmentation By Target Area, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Smart Pills Market

  • 29.1. USA Smart Pills Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Smart Pills Market, Segmentation By Target Area, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Smart Pills Market

  • 30.1. Canada Smart Pills Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Smart Pills Market, Segmentation By Target Area, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Smart Pills Market

  • 31.1. South America Smart Pills Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Smart Pills Market, Segmentation By Target Area, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Smart Pills Market

  • 32.1. Brazil Smart Pills Market, Segmentation By Target Area, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Smart Pills Market

  • 33.1. Middle East Smart Pills Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Smart Pills Market, Segmentation By Target Area, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Smart Pills Market

  • 34.1. Africa Smart Pills Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Smart Pills Market, Segmentation By Target Area, Segmentation By Disease Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Smart Pills Market Regulatory and Investment Landscape

36. Smart Pills Market Competitive Landscape And Company Profiles

  • 36.1. Smart Pills Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Smart Pills Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Smart Pills Market Company Profiles
    • 36.3.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Olympus Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. CapsoVision Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Proteus Digital Health Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Smart Pills Market Other Major And Innovative Companies

  • Koninklijke Philips N.V., MicroCHIPS Inc., Bio-Images Drug Delivery (BDD) Ltd., Given Imaging Ltd., Vitality Inc., Boston Scientific Corporation, HQ Inc., Fujifilm Holdings Corporation, General Electric Company, Check-Cap Ltd., IntroMedic Co. Ltd., Jinshan Science & Technology Co. Ltd., PENTAX Medical, etectRx Inc., Pixie Scientific HQ Inc.

38. Global Smart Pills Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Smart Pills Market

40. Smart Pills Market High Potential Countries, Segments and Strategies

  • 40.1 Smart Pills Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Smart Pills Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Smart Pills Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer